Clinical Trial Update: Evaluation of Safety and Efficiency of Metreleptin Treatment for Patients With Multiple Symmetric Lipomatosis (MSL) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the safety and efficacy of metreleptin in people with Madelung's disease (multiple symmetric lipomatosis); results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Madelung Disease

Drugs mentioned

• Myalept (metreleptin) (metreleptin)

Snippet

Sponsor: University of Michigan | Conditions: Lipomatosis, Multiple Symmetrical | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2025-06-12